Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.

Breast cancer research : BCR - 1 Jan 2003

Ambrosone Christine B, Moysich Kirsten B, Furberg Helena, Freudenheim Jo L, Bowman Elise D, Ahmed Sabrina, Graham Saxon, Vena John E, Shields Peter G

Abstract excerpt

BACKGROUND: Findings from previous studies regarding the association between the CYP17 genotype and breast cancer are inconsistent. We investigated the role of the MspAI genetic polymorphism in the 5' region of CYP17 on risk of breast cancer and as a modifier of reproductive risk factors. METHODS: Questionnaire and genotyping data were obtained from a population-based, case-control study of premenopausal (n =...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Polymorphism, Genetic

Share to Postmenopause

Share to Premenopause

Share to Risk Factors

Share to Steroid 17-alpha-Hydroxylase

Source

Open in PubMed Open full text

Identifiers

PMID: 12631398
DOI: 10.1186/bcr570
PMCID: PMC154148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.PMID 12631398Read ↗

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Semantic proximity Read ↗

CYP17 genotype and breast cancer risk.Semantic proximity Read ↗

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.Semantic proximity Read ↗

The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Genetic polymorphism of CYP17 and breast cancer risk in Korean women.Semantic proximity Read ↗

Association between CYP17 polymorphisms and the development of breast cancer.Semantic proximity Read ↗

A polymorphism in the CYP17 gene increases the risk of breast cancer.Semantic proximity Read ↗

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.Semantic proximity Read ↗

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.Semantic proximity Read ↗

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.Semantic proximity Read ↗

CYP17 and breast cancer: no overall effect, but what about interactions?Semantic proximity Read ↗

Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.